DNA Damage in Healthy Individuals and Respiratory Patients after Treating Whole Blood In vitro with the Bulk and Nano Forms of NSAIDs
View/ Open
najafzadeh_et_al_2016.pdf (858.0Kb)
Download
Publication date
28/09/2016Author
Najafzadeh, MojganNormington, Charmaine
Jacob, B.K.
Isreb, Mohammad
Gopalan, Rajendran C.
Anderson, Diana
Rights
© 2016 The Authors. This is an open-access article distributed under the terms of the Creative Commons Attribution License CC-BY (http://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.Peer-Reviewed
YesOpen Access status
openAccess
Metadata
Show full item recordAbstract
Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit COX enzyme activity which affects the inflammatory response. Inflammation is associated with increasing cancer incidence. Pre-clinical and clinical studies have shown that NSAID treatment could cause an anti-tumor effect in cancers. In the present study, blood was taken from healthy individuals (n = 17) and patients with respiratory diseases or lung cancer (n = 36). White blood cells (WBC) were treated with either a micro-suspension, i.e., bulk (B) or nano-suspension (N) of aspirin (ASP) or ibuprofen (IBU) up to 500 μg/ml in the comet assay and up to 125 μg/ml in the micronucleus assay. In this study results were compared against untreated lymphocytes and their corresponding treated groups. The results showed, that NSAIDs in their nano form significantly reduced the DNA damage in WBCs from lung cancer patients in bulk and nano compared to untreated lymphocytes. Also, there was a decrease in the level of DNA damage in the comet assay after treating WBCs from healthy individuals, asthma and COPD groups with aspirin N (ASP N) but not with IBU N. In addition, the number of micronuclei decreased after treatment with NSAIDs in their nano form (ASP N and IBU N) in the healthy as well as in the lung cancer group. However, this was not the case for micronucleus frequency in asthma and COPD patients. These data show that lymphocytes from different groups respond differently to treatment with ASP and IBU as measured by comet assay and micronucleus assay, and that the size of the suspended particles of the drugs affects responses.Version
Published versionCitation
Najafzadeh M, Normington C, Jacob BK, Isreb M, Gopala RC and Anderson D (2016) DNA Damage in Healthy Individuals and Respiratory Patients after Treating Whole Blood In vitro with the Bulk and Nano Forms of NSAIDs. Frontiers in Molecular Biosciences – Nanobiotechnology. 3: Article 50.Link to Version of Record
https://doi.org/10.3389/fmolb.2016.00050Type
Articleae974a485f413a2113503eed53cd6c53
https://doi.org/10.3389/fmolb.2016.00050